SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-054522
Filing Date
2022-02-25
Accepted
2022-02-25 16:42:04
Documents
2
Group Members
WUBIN PAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d300001dsc13g.htm SC 13G 59039
2 EX-99 d300001dex99.htm EX-99 3292
  Complete submission text file 0001193125-22-054522.txt   64035
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92416 | Film No.: 22681054
SIC: 2834 Pharmaceutical Preparations

Mailing Address COASTAL BLDG WICKHAMS CAY II PO BOX 2221 ROAD TOWN TORTOLA D8 NONE
Business Address COASTAL BLDG WICKHAMS CAY II PO BOX 2221 ROAD TOWN TORTOLA D8 NONE 86 512 5357 7866
BioFortune Inc (Filed by) CIK: 0001912836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G